Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Arcus Biosciences, Inc. | rcus-ex322_135.htm |
| EX-32.1 - EX-32.1 - Arcus Biosciences, Inc. | rcus-ex321_136.htm |
| EX-31.2 - EX-31.2 - Arcus Biosciences, Inc. | rcus-ex312_137.htm |
| EX-31.1 - EX-31.1 - Arcus Biosciences, Inc. | rcus-ex311_138.htm |
| EX-21.1 - EX-21.1 - Arcus Biosciences, Inc. | rcus-ex211_22.htm |
| EX-10.37 - EX-10.37 - Arcus Biosciences, Inc. | rcus-ex1037_348.htm |
| EX-10.36 - EX-10.36 - Arcus Biosciences, Inc. | rcus-ex1036_349.htm |
| EX-10.35 - EX-10.35 - Arcus Biosciences, Inc. | rcus-ex1035_379.htm |
| EX-10.22 - EX-10.22 - Arcus Biosciences, Inc. | rcus-ex1022_380.htm |
| EX-4.3 - EX-4.3 - Arcus Biosciences, Inc. | rcus-ex43_381.htm |
| 10-K - 10-K - Arcus Biosciences, Inc. | rcus-10k_20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statements (Form S-3 Nos. 333-230676, and 333-238730) of Arcus Biosciences, Inc., and |
|
|
(2) |
Registration Statements (Form S-8 Nos. 333-223746, 333-230074, and 333-236915) pertaining to the Arcus Biosciences, Inc. 2018 Equity Incentive Plan, the Arcus Biosciences, Inc. Amended and Restated 2015 Stock Plan, the Arcus Biosciences, Inc. 2018 Employee Stock Purchase Plan, and the Arcus Biosciences, Inc. 2020 Inducement Plan; |
of our reports dated February 24, 2021, with respect to the consolidated financial statements of Arcus Biosciences, Inc. and the effectiveness of internal control over financial reporting of Arcus Biosciences, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Redwood City, California
February 24, 2021